Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ViaLogy selected by Cisco

1 Apr 2008 13:00

ViaLogy PLC01 April 2008 ViaLogy Technology Integrated into New Cisco Open Platform for Safety and Security London, 1 April 2008: ViaLogy PLC (LSE: VIY), a leading innovator of real-timenetwork-centric signal processing platforms, announces its technology is beingintegrated into the Cisco Open Platform for Safety and Security (COPSS), the newCisco technology platform launched today at the annual FOSE 2008 industry tradeshow. The Cisco Open Platform for Safety and Security is a secure, intelligent,converged solution intended for multiple surveillance and alert applications tosupport the growing needs of defence, civilian, public safety, state and localgovernment agencies. It is to be offered by Cisco to public sector organizationson a worldwide basis. As a core member of the solution team, ViaLogy will provide the sensorintegration engine for the platform. ViaLogy's SPMTM (Sensor Policy Manager)software enables disparate sensors in very large enterprise networks to processand report only key events of interest to security personnel. The ViaLogytechnology is sensor agnostic and considerably enhances the performance andstrength of all integrated legacy and IP sensors, thus avoiding false alarms,missed events and optimizing use of limited bandwidth. ViaLogy's SPMTM is anintegral part of the Cisco Open Platform for Safety and Security demonstration -and available for viewing - at Cisco's Center of Excellence in Herndon,Virginia. "We are pleased to be working with Vialogy as part of our go-to-market team forthe Cisco Open Platform for Safety and Security," said Bruce Klein, Cisco'sfederal vice president. "Our strategy is to pull together an 'ecosystem' of theleading companies with expertise in protecting citizens, employees and criticalassets to provide the most comprehensive solution for facilitating collaborationfor government agencies. Vialogy delivers a critical piece of our overalltechnology platform." "Cisco has developed the Cisco Open Platform for Safety and Security to answer aworldwide requirement from customers for improved and co-ordinated integratedsafety and security systems," said Robert W. Dean. President and CEO of ViaLogy,"We are proud to be chosen as an approved supplier to the platform." "SPMTM is a comprehensive and flexible product that can be customised to suitindividual customer needs because we recognise that there are a variety ofsituations to be dealt with. Some customers will want a complete system forsecuring or monitoring a new building or area, others will want the overallintegration of existing and new security arrangements. "The Cisco Open Platform for Safety and Security will give common operationalpicture vigilance of all aspects of security, faster situation assessment,automated decision making and improved response time." ViaLogy has been closely involved in the development of an Improved DecisionSupport System for disparate sensors. As the Department of Defense drivesconvergence of physical security, consequence management and Chemical,Biological, Radiological/Nuclear, and Explosive (CBRNE) incidents to ensuresafety of military bases, scaleable network-centric technologies and IT productsare becoming increasingly important. ViaLogy has demonstrated its successes overthe past year during multiple Department of Defense demonstrations thatcontinually monitored and reported on CBRNE sensors in realistic scenarios.ViaLogy's SPMTM technology flawlessly linked all critical sensors to enableautomatic time alerts to the right person. This sensor integration andinteroperability capability will be a critical factor in next generationnetworked emergency alert systems. To find out more about the Cisco Open Platform for Safety and Security andViaLogy's participation please visit www.vialogy.com. ends Further information from: ViaLogy Robert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0)1235 834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0)20 7107 8000 PR Consultants - Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defence and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.